{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:23:59Z","timestamp":1791260639431,"version":"4.1.0"},"reference-count":315,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1466100"],"award-info":[{"award-number":["24ZR1466100"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073951"],"award-info":[{"award-number":["82073951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phrs.2025.107849","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:42:55Z","timestamp":1751431375000},"page":"107849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential"],"prefix":"10.1016","volume":"218","author":[{"given":"Yingxuan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Maisenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0704-2943","authenticated-orcid":false,"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2025.107849_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2025.107849_bib2","unstructured":"M. Prince, A. Wimo, M. Guerchet, G.-C. Ali, Y.-T. Wu, M. Prina, World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends, (2015)."},{"key":"10.1016\/j.phrs.2025.107849_bib3","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer's disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer's disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in Parkinson's disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann. Agric. Environ. Med"},{"key":"10.1016\/j.phrs.2025.107849_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson's syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu Rev. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030719","article-title":"Novel approaches for the treatment of Alzheimer's and Parkinson's disease","volume":"20","author":"Van Bulck","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2025.107849_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fncel.2015.00124","article-title":"Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases","volume":"9","author":"Chin-Chan","year":"2015","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.phrs.2025.107849_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2025.107849_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128238","article-title":"The association between toxic pesticide environmental exposure and Alzheimer's disease: a scientometric and visualization analysis","volume":"263","author":"Li","year":"2021","journal-title":"Chemosphere"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s43587-025-00844-y","article-title":"A systematic review with a Burden of Proof meta-analysis of health effects of long-term ambient fine particulate matter (PM(2.5)) exposure on dementia","volume":"5","author":"Huang","year":"2025","journal-title":"Nat. Aging"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41591-024-03453-1","article-title":"Bioaccumulation of microplastics in decedent human brains","volume":"31","author":"Nihart","year":"2025","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/toxics13020114","article-title":"Epigenetic biomarkers driven by environmental toxins associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the United States: a systematic review","volume":"13","author":"Newell","year":"2025","journal-title":"Toxics"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/mds.28922","article-title":"Air pollution and the risk of Parkinson's disease: a review","volume":"37","author":"Murata","year":"2022","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib16","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1007\/s12035-023-03805-x","article-title":"Environmental Toxins and Alzheimer's disease: a comprehensive analysis of pathogenic mechanisms and therapeutic modulation","volume":"61","author":"Dhapola","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107849_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104852","article-title":"Environmental toxins and Alzheimer's disease progression","volume":"141","author":"Vasefi","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2025.107849_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/03602530500251220","article-title":"drug metabolism: terminology that we should phase out?","volume":"37","author":"David Josephy","year":"2005","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.phrs.2025.107849_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuro.2021.08.004","article-title":"Xenobiotic transport and metabolism in the human brain","volume":"86","author":"Silva-Adaya","year":"2021","journal-title":"Neurotoxicology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib21","first-page":"187","article-title":"The detoxification enzyme systems","volume":"3","author":"Liska","year":"1998","journal-title":"Alter. Med Rev."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST20150139","article-title":"ABC transporter research: going strong 40 years on","volume":"43","author":"Theodoulou","year":"2015","journal-title":"Biochem Soc. Trans."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib23","first-page":"263","article-title":"Basic review of the cytochrome p450 system","volume":"4","author":"McDonnell","year":"2013","journal-title":"J. Adv. Pr. Oncol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.arr.2008.04.001","article-title":"Detoxification reactions: relevance to aging","volume":"7","author":"Zimniak","year":"2008","journal-title":"Ageing Res Rev."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2000-9388","article-title":"Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters","volume":"20","author":"Kipp","year":"2000","journal-title":"Semin Liver Dis."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2133\/dmpk.24.139","article-title":"Tissue-specific mRNA expression profiles of drug-metabolizing enzymes and transporters in the cynomolgus monkey","volume":"24","author":"Nishimura","year":"2009","journal-title":"Drug Metab. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2020.1858856","article-title":"Cytochrome P450 expression and regulation in the brain","volume":"53","author":"Kuban","year":"2021","journal-title":"Drug Metab. Rev."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib28","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.bjp.0705146","article-title":"Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics","volume":"138","author":"Howard","year":"2003","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib29","first-page":"243","article-title":"Differential metabolism of alprazolam by liver and brain cytochrome (P4503A) to pharmacologically active metabolite","volume":"2","author":"Pai","year":"2002","journal-title":"Pharm. J."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib30","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1124\/dmd.109.027011","article-title":"Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function","volume":"37","author":"Dutheil","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2005.03061.x","article-title":"Constitutive expression and localization of cytochrome P-450 1A1 in rat and human brain: presence of a splice variant form in human brain","volume":"93","author":"Chinta","year":"2005","journal-title":"J. Neurochem."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107849_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0169-328X(02)00177-8","article-title":"Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain","volume":"103","author":"Chinta","year":"2002","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0006-8993(89)90493-9","article-title":"Distribution and possible metabolic role of class III alcohol dehydrogenase in the human brain","volume":"481","author":"Giri","year":"1989","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00702-014-1320-1","article-title":"Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease","volume":"123","author":"Grunblatt","year":"2016","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2990.1990.tb01264.x","article-title":"Glutathione S-transferase in human brain","volume":"16","author":"Carder","year":"1990","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/002215540305101209","article-title":"Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study","volume":"51","author":"Liyou","year":"2003","journal-title":"J. Histochem Cytochem"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/toxsci\/kfj061","article-title":"Human sulfotransferases and their role in chemical metabolism","volume":"90","author":"Gamage","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib38","first-page":"445","article-title":"Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain","volume":"8","author":"Salman","year":"2011","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-9926(199811)58:5<174::AID-TERA3>3.0.CO;2-Q","article-title":"Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain","volume":"58","author":"Stanley","year":"1998","journal-title":"Teratology"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1742-7843.2005.pto_02.x","article-title":"Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts","volume":"96","author":"Boukouvala","year":"2005","journal-title":"Basic Clin. Pharm. Toxicol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib41","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/epi.12318","article-title":"Expression and functional relevance of UGT1A4 in a cohort of human drug-resistant epileptic brains","volume":"54","author":"Ghosh","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib42","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abbi.1999.1155","article-title":"Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate","volume":"365","author":"King","year":"1999","journal-title":"Arch. Biochem Biophys."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2023.2297154","article-title":"The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure","volume":"56","author":"Zhang","year":"2024","journal-title":"Drug Metab. Rev."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.wnr.0000221833.41340.cd","article-title":"Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells","volume":"17","author":"Kim","year":"2006","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1055\/s-0028-1103272","article-title":"ABC transporter (P-gp\/ABCB1, MRP1\/ABCC1, BCRP\/ABCG2) expression in the developing human CNS","volume":"39","author":"Daood","year":"2008","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","article-title":"Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain","volume":"129","author":"Nies","year":"2004","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156516","article-title":"Functional Cooperativity between ABCG4 and ABCG1 Isoforms","volume":"11","author":"Hegyi","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051563","article-title":"Differential expression of ABC transporter genes in brain vessels vs. peripheral tissues and vessels from human, mouse and rat","volume":"15","author":"Zhang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.phrs.2025.107849_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mad.2014.08.003","article-title":"Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary","volume":"141-142","author":"Bernstein","year":"2014","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.phrs.2025.107849_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exger.2017.12.015","article-title":"Aging, inflammation and the environment","volume":"105","author":"Bektas","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.phrs.2025.107849_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107523","article-title":"Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders","volume":"210","author":"Costa","year":"2020","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.107849_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2020.106376","article-title":"Long-term exposure to ambient air pollution and risk of dementia: results of the prospective Three-City study","volume":"148","author":"Mortamais","year":"2021","journal-title":"Environ. Int."},{"issue":"10248","key":"10.1016\/j.phrs.2025.107849_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"37","key":"10.1016\/j.phrs.2025.107849_bib54","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.1809474115","article-title":"The impact of exposure to air pollution on cognitive performance","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"s1","key":"10.1016\/j.phrs.2025.107849_bib55","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.3233\/JAD-180631","article-title":"Air pollution and dementia: a systematic review","volume":"70","author":"Peters","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2025.107849_bib56","article-title":"Bioaccumulation of microplastics in decedent human brains","author":"Nihart","year":"2025","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107849_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128238","article-title":"The association between toxic pesticide environmental exposure and Alzheimer's disease: a scientometric and visualization analysis","volume":"263","author":"Li","year":"2021","journal-title":"Chemosphere"},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib58","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/156720511797633197","article-title":"Amyloid beta peptide levels increase in brain of A beta PP Swedish mice after exposure to chlorpyrifos","volume":"8","author":"G. Salazar","year":"2011","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.phrs.2025.107849_bib59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.fct.2017.05.067","article-title":"The toxic influence of paraquat on hippocampal neurogenesis in adult mice","volume":"106","author":"Li","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/1028415X.2018.1492772","article-title":"Crocin-protected malathion-induced spatial memory deficits by inhibiting TAU protein hyperphosphorylation and antiapoptotic effects","volume":"23","author":"Mohammadzadeh","year":"2020","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13607863.2012.742488","article-title":"The impact of alcohol on Alzheimer's disease: a systematic review","volume":"17","author":"Piazza-Gardner","year":"2013","journal-title":"Aging Ment. Health"},{"issue":"30","key":"10.1016\/j.phrs.2025.107849_bib62","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1016\/j.febslet.2008.11.007","article-title":"Alcohol enhances Abeta42-induced neuronal cell death through mitochondrial dysfunction","volume":"582","author":"Lee","year":"2008","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119492","article-title":"Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies","volume":"24","author":"Chandrashekar","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"33","key":"10.1016\/j.phrs.2025.107849_bib64","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer's disease","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib65","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1007\/s12035-018-0952-9","article-title":"CYP46A1 and the APOEepsilon4 allele polymorphisms correlate with the risk of Alzheimer's disease","volume":"55","author":"Li","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2025.107849_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2016.03.048","article-title":"The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: a meta-analysis","volume":"620","author":"Jia","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib67","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00415-012-6690-4","article-title":"CYP46A1 T\/C polymorphism associated with the APOE epsilon4 allele increases the risk of Alzheimer's disease","volume":"260","author":"Li","year":"2013","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107849_bib69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2014.05.033","article-title":"Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis","volume":"343","author":"Lu","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107849_bib70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2015.03.024","article-title":"CYP2J2 rs890293 polymorphism is associated with susceptibility to Alzheimer's disease in the Chinese Han population","volume":"593","author":"Yan","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(03)00438-X","article-title":"Dehydroepiandrosterone 7-hydroxylase CYP7B: predominant expression in primate hippocampus and reduced expression in Alzheimer's disease","volume":"121","author":"Yau","year":"2003","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-2011-110860","article-title":"Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome","volume":"28","author":"Chace","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.phrs.2025.107849_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.039461","article-title":"CYP19 haplotypes increase risk for Alzheimer's disease","volume":"43","author":"Huang","year":"2006","journal-title":"J. Med Genet"},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib74","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.WNL.0000118208.16939.60","article-title":"Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease","volume":"62","author":"Iivonen","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib75","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-008-0028-5","article-title":"Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk","volume":"115","author":"Combarros","year":"2008","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib76","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neulet.2009.10.089","article-title":"Association of the aromatase gene with Alzheimer's disease in women","volume":"468","author":"Butler","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib77","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1159\/000221832","article-title":"Genetic variation of CYP19 (Aromatase) gene influences age at onset of Alzheimer's disease in women","volume":"27","author":"Corbo","year":"2009","journal-title":"Dement Geriatr. Cogn."},{"issue":"2-3","key":"10.1016\/j.phrs.2025.107849_bib78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000087065","article-title":"Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk","volume":"20","author":"Combarros","year":"2005","journal-title":"Dement Geriatr. Cogn."},{"key":"10.1016\/j.phrs.2025.107849_bib79","article-title":"Associations of Alcohol Dehydrogenase and aldehyde dehydrogenase polymorphism with cognitive impairment among the oldest-old in China","volume":"13","author":"Jin","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib80","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15048740","article-title":"Role of ADH1B rs1229984 and ALDH2 rs671 gene polymorphisms in the development of Alzheimer's disease","volume":"15","author":"Ma","year":"2016","journal-title":"Genet Mol. Res"},{"key":"10.1016\/j.phrs.2025.107849_bib81","article-title":"Association Study of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Polymorphism With Alzheimer Disease in the Taiwanese Population","volume":"15","author":"Wu","year":"2021","journal-title":"Front Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib82","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-215627","article-title":"Association study and meta-analysis of polymorphisms and blood mRNA expression of the ALDH2 gene in patients with Alzheimer's disease","volume":"87","author":"Ueno","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107849_bib83","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jns.2007.12.006","article-title":"The association of mitochondrial aldehyde dehydrogenase gene (ALDH2) polymorphism with susceptibility to late-onset Alzheimer's disease in Chinese","volume":"268","author":"Wang","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2025.107849_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.710966","article-title":"Associations of alcohol dehydrogenase and aldehyde dehydrogenase polymorphism with cognitive impairment among the oldest-old in China","volume":"13","author":"Jin","year":"2022","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib85","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.2000.2923","article-title":"Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population","volume":"273","author":"Kamino","year":"2000","journal-title":"Biochem Biophys. Res Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib86","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1212\/WNL.51.6.1562","article-title":"Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease","volume":"51","author":"Lovell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107849_bib87","doi-asserted-by":"crossref","first-page":"1517613","DOI":"10.3389\/fnagi.2024.1517613","article-title":"Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer's disease","volume":"16","author":"Tang","year":"2024","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib88","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ajp.2012.02.023","article-title":"A preliminary study on the influence of glutathione S transferase T1 (GSTT1) as a risk factor for late onset Alzheimer's disease in North Indian population","volume":"5","author":"Ghosh","year":"2012","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib89","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/01616412.2017.1390902","article-title":"Association of glutathione S-transferases M1, P1 and T1 variations and risk of late-onset Alzheimer's disease","volume":"40","author":"Jafarian","year":"2018","journal-title":"Neurol. Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib90","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2011.11.005","article-title":"GSTO1*E155del polymorphism associated with increased risk for late-onset Alzheimer's disease: association hypothesis for an uncommon genetic variant","volume":"506","author":"Piacentini","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib91","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12035-015-9092-7","article-title":"GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer\u2019s Disease: a Meta-Analysis","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0891988714522698","article-title":"Polymorphism in cytochrome P450 2D6, glutathione S-transferases Pi 1 genes, and organochlorine pesticides in Alzheimer disease: a case-control study in North Indian population","volume":"27","author":"Singh","year":"2014","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.phrs.2025.107849_bib93","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuro.2013.08.002","article-title":"Modifying roles of glutathione S-transferase polymorphisms on the association between cumulative lead exposure and cognitive function","volume":"39","author":"Eum","year":"2013","journal-title":"Neurotoxicology"},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib94","first-page":"1112","article-title":"N-acetyltransferase 2 gene polymorphism in a group of senile dementia patients in Shanghai suburb","volume":"25","author":"Guo","year":"2004","journal-title":"Acta Pharm. Sin."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108447","article-title":"Reduction of mNAT1\/hNAT2 contributes to cerebral endothelial necroptosis and abeta accumulation in Alzheimer's disease","volume":"33","author":"Zou","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-019-01994-1","article-title":"The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics","volume":"138","author":"De Roeck","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib98","doi-asserted-by":"crossref","first-page":"164","DOI":"10.31083\/j.jin2309164","article-title":"Alzheimer's disease and effects of ABCA7 polymorphisms: a review","volume":"23","author":"Gialama","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib99","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.1007\/s12035-023-03414-8","article-title":"ABCA7-associated clinical features and molecular mechanisms in Alzheimer's disease","volume":"60","author":"Qian","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib100","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1002\/alz.13805","article-title":"The ABC's of Alzheimer risk gene ABCA7","volume":"20","author":"Duchateau","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib101","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3233\/ADR-230072","article-title":"Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population","volume":"7","author":"Ding","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib102","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnen\/nlae060","article-title":"Very low levels of ABCA7 in the cerebrum and Alzheimer's disease onset between the ages of 60 and 80 independently of APOE","volume":"83","author":"Garliyev","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.phrs.2025.107849_bib103","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neulet.2017.11.027","article-title":"ABCA1 rs2230805 and rs2230806 common gene variants are associated with Alzheimer's disease","volume":"664","author":"Feher","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib104","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","article-title":"Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease","volume":"11","author":"Nordestgaard","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11011-020-00577-4","article-title":"Association of genetic variants of ABCA1 with susceptibility to dementia: (SADEM study)","volume":"35","author":"Teresa","year":"2020","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.phrs.2025.107849_bib106","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s10072-016-2579-9","article-title":"Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer's disease: a meta-analysis","volume":"37","author":"Chen","year":"2016","journal-title":"Neurol. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib107","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2174\/1567205020666221114112838","article-title":"Association between ABCA1 R219K variant and Alzheimer's disease: an updated meta-analysis and systematic review","volume":"19","author":"Zhao","year":"2022","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.phrs.2025.107849_bib108","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.12659\/MSM.903636","article-title":"Differences in ABCA1 R219K Polymorphisms and Serum Indexes in Alzheimer and Parkinson diseases in Northern China","volume":"23","author":"Ya","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.phrs.2025.107849_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-022-01208-7","article-title":"Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease","author":"Holstege","year":"2022","journal-title":"Nat. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2004.09.011","article-title":"ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease","volume":"18","author":"Mac\u00e9","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2025.107849_bib111","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.12659\/MSM.905524","article-title":"ATP binding cassette subfamily a member 2 (ABCA2) expression and methylation are associated with Alzheimer's disease","volume":"23","author":"Hu","year":"2017","journal-title":"Med Sci. Monit."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib112","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-022-00536-w","article-title":"The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease","volume":"17","author":"Bossaerts","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.phrs.2025.107849_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2013.06.044","article-title":"Association between the ABCG2 C421A polymorphism and Alzheimer's disease","volume":"550","author":"Feher","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107849_bib114","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2013.06.044","article-title":"Association between the ABCG2 C421A polymorphism and Alzheimer's disease","volume":"550","author":"Feh\u00e9r","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12031-014-0427-z","article-title":"ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease","volume":"54","author":"Feher","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2025.107849_bib116","doi-asserted-by":"crossref","first-page":"32708","DOI":"10.1038\/srep32708","article-title":"Association between ABCB1 polymorphisms and haplotypes and Alzheimer's disease: a meta-analysis","volume":"6","author":"Zhong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107849_bib117","first-page":"209","article-title":"Influence of CYP2D6, CYP3A5, ABCB1, APOE polymorphisms and nongenetic factors on donepezil treatment in patients with Alzheimer's disease and vascular dementia","volume":"12","author":"Yaowaluk","year":"2019","journal-title":"Pharmgenomics Pers. Med."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib118","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-141320","article-title":"ABCA5 regulates amyloid-\u03b2 peptide production and is associated with Alzheimer's disease neuropathology","volume":"43","author":"Fu","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"23","key":"10.1016\/j.phrs.2025.107849_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235490","article-title":"Preferred endocytosis of amyloid precursor protein from cholesterol-enriched lipid raft microdomains","volume":"25","author":"Cho","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib120","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1096\/fj.10-168633","article-title":"Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis","volume":"25","author":"Marquer","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2025.107849_bib121","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","article-title":"Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease","volume":"123","author":"Mast","year":"2017","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068534","article-title":"Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?","volume":"8","author":"Maioli","year":"2013","journal-title":"Plos One"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib123","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-022-01151-z","article-title":"CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease","volume":"14","author":"Lerner","year":"2022","journal-title":"Alzheimers Res. Ther."},{"issue":"Pt 8","key":"10.1016\/j.phrs.2025.107849_bib124","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib125","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa043","article-title":"Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes","volume":"2","author":"Petrov","year":"2020","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib126","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41467-022-28769-9","article-title":"ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib127","first-page":"671","article-title":"Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease","volume":"118","author":"Wahrle","year":"2008","journal-title":"J. Clin. Invest"},{"issue":"44","key":"10.1016\/j.phrs.2025.107849_bib128","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","article-title":"ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice","volume":"285","author":"Donkin","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.phrs.2025.107849_bib129","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","article-title":"Critical role of astroglial apolipoprotein E and liver X receptor-alpha expression for microglial Abeta phagocytosis","volume":"31","author":"Terwel","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2025.107849_bib130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbi.2017.05.012","article-title":"Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease","volume":"65","author":"Yang","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib131","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 Agonist Reverses the ApoE4-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib132","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13195-022-01028-1","article-title":"Effect of the ABCA1 agonist CS-6253 on amyloid-beta and lipoprotein metabolism in cynomolgus monkeys","volume":"14","author":"Noveir","year":"2022","journal-title":"Alzheimers Res Ther."},{"issue":"38","key":"10.1016\/j.phrs.2025.107849_bib133","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib134","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3233\/JAD-170883","article-title":"A.B.C.A.7 Downregulation Modifies, Cellular cholesterol homeostasis and decreases amyloid-beta peptide efflux in an in vitro model of the blood-brain barrier","volume":"64","author":"Lamartini\u00e8re","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib135","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac120","article-title":"Sex-specific lipid dysregulation in the Abca7 knockout mouse brain","volume":"4","author":"Fu","year":"2022","journal-title":"Brain Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib136","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/s41467-024-46899-0","article-title":"The aldehyde dehydrogenase 2 rs671 variant enhances amyloid beta pathology","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107849_bib137","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00045","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease","volume":"4","author":"Elali","year":"2013","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib138","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","article-title":"Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease","volume":"28","author":"Liao","year":"2017","journal-title":"Curr. Opin. Lipido"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib139","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamaneurol.2020.3536","article-title":"Novel Alzheimer disease risk loci and pathways in african american individuals using the african genome resources panel: a meta-analysis","volume":"78","author":"Kunkle","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib140","article-title":"The combined risk effect among BIN1, CLU, and APOE genes in Alzheimer's disease","volume":"43","author":"dos Santos","year":"2020","journal-title":"Genet Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib141","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/acn3.506","article-title":"ABCA7 and risk of dementia and vascular disease in the Danish population","volume":"5","author":"Kjeldsen","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib142","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13195-015-0154-x","article-title":"Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans","volume":"7","author":"Del-Aguila","year":"2015","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib143","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13195-019-0563-3","article-title":"ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEepsilon4-associated Alzheimer's disease","volume":"11","author":"Chang","year":"2019","journal-title":"Alzheimers Res Ther."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib144","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JAD-160456","article-title":"ABCA7 mediates phagocytic clearance of amyloid-beta in the brain","volume":"54","author":"Fu","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"13","key":"10.1016\/j.phrs.2025.107849_bib145","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","article-title":"ABCA7 deficiency accelerates amyloid-beta generation and Alzheimer's neuronal pathology","volume":"36","author":"Sakae","year":"2016","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib146","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib147","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","article-title":"MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier","volume":"17","author":"Kuhnke","year":"2007","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010246","article-title":"New evidence for P-gp-mediated export of amyloid-beta PEPTIDES in molecular, blood-brain barrier and neuronal models","volume":"22","author":"Chai","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib149","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/1567205013666161201201227","article-title":"Lack of P-glycoprotein results in impairment of removal of beta-amyloid and increased intraparenchymal cerebral amyloid angiopathy after active immunization in a transgenic mouse model of Alzheimer's disease","volume":"14","author":"Bruckmann","year":"2017","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.phrs.2025.107849_bib150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib151","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A Role for P-glycoprotein in clearance of alzheimer amyloid beta -peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res"},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib152","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-\u03b2 proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J. Clin. Invest"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib153","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-150350","article-title":"Age-dependent regulation of the blood-brain barrier influx\/efflux equilibrium of amyloid-beta peptide in a mouse model of Alzheimer's disease (3xTg-AD)","volume":"49","author":"Do","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2025.107849_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120011","article-title":"Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: a first step of a potential strategy for the treatment of Alzheimer's disease","volume":"591","author":"Arduino","year":"2020","journal-title":"Int J. Pharm."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031231","article-title":"Blood-brain barrier disruption increases amyloid-related pathology in TgSwDI mice","volume":"22","author":"Abdallah","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib156","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1471-4159.2010.06887.x","article-title":"ABCG2 reduces ROS-mediated toxicity and inflammation: a potential role in Alzheimer's disease","volume":"114","author":"Shen","year":"2010","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155400","article-title":"ABCG1 and ABCG4 Suppress gamma-Secretase Activity and Amyloid beta Production","volume":"11","author":"Sano","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib158","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1038\/s41598-017-13750-0","article-title":"Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-beta peptide","volume":"7","author":"Dodacki","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107849_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res Rev."},{"issue":"61","key":"10.1016\/j.phrs.2025.107849_bib160","first-page":"193","article-title":"Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease","author":"Balcz","year":"2001","journal-title":"J. Neural Transm. Suppl."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib161","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1517\/17425255.4.6.697","article-title":"Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily","volume":"4","author":"Marchitti","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib162","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-2006-9208","article-title":"Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification","volume":"9","author":"Ohta","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/09298673113209990181","article-title":"4-Hydroxynonenal in the pathogenesis and progression of human diseases","volume":"21","author":"Shoeb","year":"2014","journal-title":"Curr. Med Chem."},{"issue":"24","key":"10.1016\/j.phrs.2025.107849_bib164","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1523\/JNEUROSCI.4956-07.2008","article-title":"Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity","volume":"28","author":"Ohsawa","year":"2008","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib165","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1471-4159.2011.07343.x","article-title":"Glutathione-S-transferase P1 is a critical regulator of Cdk5 kinase activity","volume":"118","author":"Sun","year":"2011","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib166","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/acschemneuro.0c00096","article-title":"Physiological and pathological roles of Cdk5: potential directions for therapeutic targeting in neurodegenerative disease","volume":"11","author":"Allnutt","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib167","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib168","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s40478-019-0839-7","article-title":"Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer's disease related pathology","volume":"7","author":"Joshi","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib169","first-page":"451","article-title":"Parkinson's disease is predominantly an environmental disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J. Park. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-023-00568-z","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson's disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"NPJ Park. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib171","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.281.4.341","article-title":"Parkinson disease in twins: an etiologic study","volume":"281","author":"Tanner","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib172","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.25441","article-title":"Concordance for Parkinson's disease in twins: a 20-year update","volume":"85","author":"Goldman","year":"2019","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib173","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107849_bib174","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson's Disease and the Environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front Neurol."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib175","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib176","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib177","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jnr.21159","article-title":"Chronic rotenone treatment induces behavioral effects but no pathological signs of parkinsonism in mice","volume":"85","author":"Richter","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib178","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1007\/s12035-015-9309-9","article-title":"PPARbeta\/delta agonist provides neuroprotection by suppression of IRE1alpha-caspase-12-mediated endoplasmic reticulum stress pathway in the rotenone rat model of Parkinson's disease","volume":"53","author":"Tong","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib179","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091107","article-title":"Neuroprotective effects of a standardized flavonoid extract from safflower against a rotenone-induced rat model of Parkinson's disease","volume":"21","author":"Ablat","year":"2016","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib181","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4103\/1673-5374.249847","article-title":"Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach","volume":"14","author":"Bisbal","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib182","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures, Brain Res","volume":"134","author":"Testa","year":"2005","journal-title":"Mol. Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib183","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/toxsci\/kfi304","article-title":"Paraquat neurotoxicity is distinct from that of MPTP and rotenone","volume":"88","author":"Richardson","year":"2005","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib184","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1081\/CLT-100100926","article-title":"Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review","volume":"38","author":"Jones","year":"2000","journal-title":"J. Toxicol. Clin. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib185","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M708597200","article-title":"Complex I is the major site of mitochondrial superoxide production by paraquat","volume":"283","author":"Cochem\u00e9","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib186","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/jnc.14299","article-title":"HFE genotype restricts the response to paraquat in a mouse model of neurotoxicity","volume":"145","author":"Nixon","year":"2018","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib187","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1089\/ars.2009.2459","article-title":"The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death","volume":"11","author":"Cristovao","year":"2009","journal-title":"Antioxid. Redox Signal"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib188","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/ejn.14683","article-title":"Characterization of a Parkinson's disease rat model using an upgraded paraquat exposure paradigm","volume":"52","author":"Cristovao","year":"2020","journal-title":"Eur. J. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib189","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.5.6.759","article-title":"Drug-induced parkinsonism","volume":"5","author":"Mena","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mds.870130313","article-title":"Cinnarizine-induced parkinsonism: ten years later","volume":"13","author":"Marti-Masso","year":"1998","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib191","first-page":"757","article-title":"[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]","volume":"150","author":"Llau","year":"1994","journal-title":"Rev. Neurol. (Paris)"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib192","first-page":"10","article-title":"[Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs]","volume":"11","author":"Marti Masso","year":"1996","journal-title":"Neurologia"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib193","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.2005.073999","article-title":"K. Huh, Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism","volume":"77","author":"Lee","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib194","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/11598540-000000000-00000","article-title":"Drug-induced parkinsonism in the elderly: incidence, management and prevention","volume":"29","author":"Lopez-Sendon","year":"2012","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2003.09.040","article-title":"Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum","volume":"995","author":"Meredith","year":"2004","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/syn.10177","article-title":"Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat","volume":"48","author":"Fa","year":"2003","journal-title":"Synapse"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107849_bib197","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2004.09.032","article-title":"Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain","volume":"372","author":"Reinke","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib198","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.euroneuro.2006.01.001","article-title":"Role of nigral NFkappaB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats","volume":"16","author":"Saldana","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib199","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.neurobiolaging.2011.08.014","article-title":"The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients","volume":"33","author":"Mann","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1155\/2010\/282130","article-title":"Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase-2 with Parkinson's disease","volume":"28","author":"Singh","year":"2010","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib201","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ana.20143","article-title":"Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease","volume":"55","author":"Deng","year":"2004","journal-title":"Ann. Neurol."},{"issue":"28","key":"10.1016\/j.phrs.2025.107849_bib202","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1016\/S0021-9258(17)44890-3","article-title":"Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes","volume":"265","author":"Kagimoto","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2025.107849_bib203","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1212\/WNL.56.10.1363","article-title":"Parkinson's disease, CYP2D6 polymorphism, and age","volume":"56","author":"Payami","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib204","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2298\/VSP0701025D","article-title":"[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease]","volume":"64","author":"Duri\u0107","year":"2007","journal-title":"Vojn. Pregl."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/BF01273362","article-title":"Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease","volume":"103","author":"Takakubo","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2025.107849_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.888942","article-title":"Polymorphisms of cytochromes P450 and glutathione S-transferases synergistically modulate risk for Parkinson's disease","volume":"14","author":"Fan","year":"2022","journal-title":"Front Aging Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00702-009-0221-1","article-title":"Cytochrome P450 2E1 gene polymorphisms\/haplotypes and Parkinson's disease in a Swedish population","volume":"116","author":"Shahabi","year":"2009","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib208","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00415-018-9136-9","article-title":"Association between the missense alcohol dehydrogenase rs1229984T variant with the risk for Parkinson's disease in women","volume":"266","author":"Garcia-Martin","year":"2019","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib209","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.nbd.2003.09.001","article-title":"ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia","volume":"14","author":"Galter","year":"2003","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib210","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00702-004-0212-1","article-title":"Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion\/cellular matrix and vesicle trafficking genes","volume":"111","author":"Grunblatt","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.phrs.2025.107849_bib211","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S1353-8020(11)70016-5","article-title":"Parkinson's disease: molecular risk factors","volume":"18 1","author":"Grunblatt","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.phrs.2025.107849_bib212","article-title":"Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study","volume":"2012","author":"Durrenberger","year":"2012","journal-title":"Park. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib213","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/14756366.2011.653353","article-title":"Identification of aldehyde dehydrogenase 1A1 modulators using virtual screening","volume":"28","author":"Kotraiah","year":"2013","journal-title":"J. Enzym Inhib. Med Ch"},{"key":"10.1016\/j.phrs.2025.107849_bib214","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-6-8","article-title":"Proteome analysis of human substantia nigra in Parkinson's disease","volume":"6","author":"Werner","year":"2008","journal-title":"Proteome Sci."},{"key":"10.1016\/j.phrs.2025.107849_bib215","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1016\/S1353-8020(08)70009-9","article-title":"Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD","volume":"13 3","author":"Mandel","year":"2007","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib216","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12877-022-03132-1","article-title":"An antisense Alu transposon insertion\/deletion polymorphism of ALDH1A1 may functionally associate with Parkinson's disease","volume":"22","author":"Fan","year":"2022","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.phrs.2025.107849_bib217","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.620929","article-title":"ALDH1A1 genetic variations may modulate risk of Parkinson's disease in Han Chinese population","volume":"15","author":"Fan","year":"2021","journal-title":"Front Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib218","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15038606","article-title":"Role of ADH2 and ALDH2 gene polymorphisms in the development of Parkinson's disease in a Chinese population","volume":"15","author":"Zhao","year":"2016","journal-title":"Genet Mol. Res."},{"key":"10.1016\/j.phrs.2025.107849_bib219","article-title":"Aldehyde dehydrogenase 2 is associated with cognitive functions in patients with Parkinson's disease","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib220","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11030361","article-title":"Interactions of COMT and ALDH2 genetic polymorphisms on symptoms of Parkinson's disease","volume":"11","author":"Yu","year":"2021","journal-title":"Brain Sci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib221","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000000083","article-title":"Aldehyde dehydrogenase variation enhances effect of pesticides associated with Parkinson disease","volume":"82","author":"Fitzmaurice","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib222","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.taap.2013.02.013","article-title":"Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer","volume":"268","author":"Krzeslak","year":"2013","journal-title":"Toxicol. Appl. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib223","first-page":"189","article-title":"Associations with metabolites in Chinese suggest new metabolic roles in Alzheimer's and Parkinson's diseases","volume":"29","author":"Chai","year":"2020","journal-title":"Hum. Mol. Genet"},{"issue":"24","key":"10.1016\/j.phrs.2025.107849_bib224","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/hmg\/ddg357","article-title":"Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease","volume":"12","author":"Li","year":"2003","journal-title":"Hum. Mol. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2353\/ajpath.2009.081019","article-title":"Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression","volume":"175","author":"Shi","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.phrs.2025.107849_bib226","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/mds.25216","article-title":"Genetic modification of the association of paraquat and Parkinson's disease","volume":"27","author":"Goldman","year":"2012","journal-title":"Mov. Disord."},{"issue":"9085","key":"10.1016\/j.phrs.2025.107849_bib227","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(97)03495-8","article-title":"Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease","volume":"350","author":"Bandmann","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib228","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1212\/WNL.55.4.533","article-title":"Variability and validity of polymorphism association studies in Parkinson's disease","volume":"55","author":"Tan","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib229","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/01.WNL.0000052787.87093.B8","article-title":"Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese","volume":"60","author":"Chan","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib230","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.51.6.1587","article-title":"Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease","volume":"51","author":"Agundez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2025.107849_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135260","article-title":"Association of slow acetylator genotype of N-acetyltransferase 2 with Parkinson's disease in south Indian population","volume":"735","author":"Pandi","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107849_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136734","article-title":"Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population","volume":"784","author":"Yang","year":"2022","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib233","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000044","article-title":"Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants","volume":"2","author":"Nuytemans","year":"2016","journal-title":"Neurol. Genet"},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib234","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.neurobiolaging.2013.05.022","article-title":"Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population","volume":"34","author":"Chung","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib235","first-page":"41","article-title":"Changes in sphingomyelin level affect alpha-synuclein and ABCA5 expression","volume":"2","author":"Kim","year":"2012","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2025.107849_bib236","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2014.02.025","article-title":"Novel and functional ABCB1 gene variant in sporadic Parkinson's disease","volume":"566","author":"Li","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"Pt A","key":"10.1016\/j.phrs.2025.107849_bib237","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.envres.2015.08.022","article-title":"Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease","volume":"143","author":"Narayan","year":"2015","journal-title":"Environ. Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib238","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2133\/dmpk.DMPK-12-RG-075","article-title":"Disease Study, MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan","volume":"28","author":"Kiyohara","year":"2013","journal-title":"Drug Metab. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib239","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00415-009-0089-x","article-title":"MDR1 variants and risk of Parkinson disease. Association with pesticide exposure?","volume":"256","author":"Zschiedrich","year":"2009","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib240","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archneurol.2010.101","article-title":"Interaction between ABCB1 and professional exposure to organochlorine insecticides in Parkinson disease","volume":"67","author":"Dutheil","year":"2010","journal-title":"Arch. Neurol."},{"issue":"22","key":"10.1016\/j.phrs.2025.107849_bib241","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228538","article-title":"Brain endothelial P-glycoprotein level is reduced in Parkinson's disease via a vitamin D receptor-dependent pathway","volume":"21","author":"Kim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib242","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.parkreldis.2008.11.010","article-title":"Association of a polymorphism in the ABCB1 gene with Parkinson's disease","volume":"15","author":"Westerlund","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.phrs.2025.107849_bib243","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-017-0466-5","article-title":"Parkinson's disease is associated with DNA methylation levels in human blood and saliva","volume":"9","author":"Chuang","year":"2017","journal-title":"Genome Med"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib244","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/acn3.167","article-title":"ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout","volume":"2","author":"Matsuo","year":"2015","journal-title":"Ann. Clin. Transl. Neur"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib245","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1096-8628(19960726)67:4<361::AID-AJMG8>3.0.CO;2-P","article-title":"Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families","volume":"67","author":"Lucotte","year":"1996","journal-title":"Am. J. Med Genet"},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib246","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084413","article-title":"CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One"},{"issue":"8800","key":"10.1016\/j.phrs.2025.107849_bib247","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0140-6736(92)90537-D","article-title":"Mutant debrisoquine hydroxylation genes in Parkinson's disease","volume":"339","author":"Armstrong","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib248","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.jbchem.a124164","article-title":"A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease","volume":"114","author":"Tsuneoka","year":"1993","journal-title":"J. Biochem"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib249","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neulet.2007.03.024","article-title":"Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component","volume":"418","author":"Perez-Pastene","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neurol.2020.03.013","article-title":"Effects of glutathione S-transferase M1 and T1 deletions on Parkinson's disease risk among a North African population","volume":"177","author":"Rebai","year":"2021","journal-title":"Rev. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib251","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ajmg.b.30450","article-title":"Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease","volume":"144b","author":"Golbe","year":"2007","journal-title":"Am. J. Med Genet B Neuropsychiatr. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib252","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01286-7","article-title":"Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease","volume":"337","author":"Kelada","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2025.107849_bib253","doi-asserted-by":"crossref","first-page":"9235358","DOI":"10.1155\/2022\/9235358","article-title":"Bioinformatic analysis of genetic factors from human blood samples and postmortem brains in Parkinson's Disease","volume":"2022","author":"Yao","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib254","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13205-020-2162-1","article-title":"Molecular evidence of impaired iron metabolism and its association with Parkinson's disease progression","volume":"10","author":"Chi","year":"2020","journal-title":"3 Biotech"},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib255","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3565(25)12922-4","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease","volume":"277","author":"Coleman","year":"1996","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib256","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.115.226373","article-title":"P-glycoprotein transport of neurotoxic pesticides","volume":"355","author":"Lacher","year":"2015","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.phrs.2025.107849_bib257","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2011.06.051","article-title":"Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system","volume":"1408","author":"Anderson","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031522","article-title":"Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease","volume":"7","author":"Wey","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030836","article-title":"Tat-GSTpi inhibits dopaminergic cells against MPP(+)-induced cellular damage via the reduction of oxidative stress and MAPK activation","volume":"11","author":"Choi","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib260","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.0610978104","article-title":"GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism","volume":"104","author":"Smeyne","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2025.107849_bib261","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2741\/e548","article-title":"GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death","volume":"4","author":"Chen","year":"2012","journal-title":"Front Biosci. (Elite Ed. )"},{"issue":"1-2","key":"10.1016\/j.phrs.2025.107849_bib262","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11010-018-3415-8","article-title":"Inhibition of glutathione S-transferase-pi triggers c-jun N-terminal kinase-dependent neuronal death in Zn-induced Parkinsonism","volume":"452","author":"Chauhan","year":"2019","journal-title":"Mol. Cell Biochem"},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib263","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/jnc.12515","article-title":"The putative multidrug resistance protein MRP-7 inhibits methylmercury-associated animal toxicity and dopaminergic neurodegeneration in Caenorhabditis elegans","volume":"128","author":"VanDuyn","year":"2014","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092491","article-title":"UBL3 Interaction with \u03b1-synuclein is downregulated by silencing MGST3","volume":"11","author":"Yan","year":"2023","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.phrs.2025.107849_bib265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137353","article-title":"Alpha-synuclein interaction with UBL3 is upregulated by microsomal glutathione S-transferase 3, leading to increased extracellular transport of the alpha-synuclein under oxidative stress","volume":"25","author":"Yan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib266","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","article-title":"Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions","volume":"113","author":"Jang","year":"2010","journal-title":"J. Neurochem."},{"issue":"35","key":"10.1016\/j.phrs.2025.107849_bib267","first-page":"7479","article-title":"Monoamine oxidase-B inhibition facilitates alpha-synuclein secretion in vitro and delays its aggregation in rAAV-based rat models of Parkinson's disease","volume":"41","author":"Nakamura","year":"2021","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib268","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"Riddell","year":"2007","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.phrs.2025.107849_bib269","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresbull.2021.11.004","article-title":"TO901317 activation of LXR-dependent pathways mitigate amyloid-beta peptide-induced neurotoxicity in 3D human neural stem cell culture scaffolds and AD mice","volume":"178","author":"Chiang","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib270","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neuron.2024.05.021","article-title":"Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist","volume":"112","author":"Litvinchuk","year":"2024","journal-title":"Neuron"},{"issue":"25","key":"10.1016\/j.phrs.2025.107849_bib271","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1073\/pnas.0701096104","article-title":"Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors","volume":"104","author":"Zelcer","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib272","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"Koldamova","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.phrs.2025.107849_bib273","doi-asserted-by":"crossref","first-page":"27688","DOI":"10.1074\/jbc.M300760200","article-title":"Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.107849_bib274","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2017.07.053","article-title":"Amelioration of amyloid beta-induced retinal inflammatory responses by a LXR agonist TO901317 is associated with inhibition of the NF-kappaB signaling and NLRP3 inflammasome","volume":"360","author":"Lei","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107849_bib275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-2-20","article-title":"Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment","volume":"2","author":"Lefterov","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib276","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174470","article-title":"Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease","volume":"12","author":"Paterniti","year":"2017","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.phrs.2025.107849_bib277","doi-asserted-by":"crossref","first-page":"13112","DOI":"10.1073\/pnas.1210833109","article-title":"Liver X receptor beta protects dopaminergic neurons in a mouse model of Parkinson disease","volume":"109","author":"Dai","year":"2012","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.phrs.2025.107849_bib278","series-title":"Cholesterol is a strong promoter of an \u03b1-Synuclein membrane binding mode that accelerates oligomerization","author":"Jakubec","year":"2019"},{"key":"10.1016\/j.phrs.2025.107849_bib279","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fphar.2016.00456","article-title":"Pregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions","volume":"7","author":"Pavek","year":"2016","journal-title":"Front Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/er.2001-0038","article-title":"The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism","volume":"23","author":"Kliewer","year":"2002","journal-title":"Endocr. Rev."},{"issue":"8825","key":"10.1016\/j.phrs.2025.107849_bib281","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/0140-6736(92)92870-L","article-title":"Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients","volume":"340","author":"Namba","year":"1992","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib282","first-page":"771","article-title":"Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy","volume":"145","author":"Chui","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2025.107849_bib283","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fphys.2018.01520","article-title":"Repurposing proteostasis-modifying drugs to prevent or treat age-related dementia: a systematic review","volume":"9","author":"Heard","year":"2018","journal-title":"Front Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib284","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"O.M. O'D, M. Chernesky, A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease","volume":"52","author":"Loeb","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"issue":"Pt 5","key":"10.1016\/j.phrs.2025.107849_bib285","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/aww042","article-title":"Rifampicin is a candidate preventive medicine against amyloid-\u03b2 and tau oligomers","volume":"139","author":"Umeda","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.phrs.2025.107849_bib286","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-200690","article-title":"Rifampicin Suppresses amyloid-\u03b2 accumulation through enhancing autophagy in the hippocampus of a lipopolysaccharide-induced mouse model of cognitive decline","volume":"79","author":"Zhu","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2025.107849_bib287","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroscience.2014.12.033","article-title":"Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: role of pregnane x receptors","volume":"288","author":"Kaur","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2025.107849_bib288","first-page":"347","article-title":"Cytochrome P450 enzyme mediated herbal drug interactions (Part 1)","volume":"13","author":"Wanwimolruk","year":"2014","journal-title":"EXCLI J."},{"issue":"6","key":"10.1016\/j.phrs.2025.107849_bib289","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/bph.14936","article-title":"Clinical relevance of St. John's wort drug interactions revisited","volume":"177","author":"Nicolussi","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2025.107849_bib290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopha.2017.09.114","article-title":"Hyperforin attenuates aluminum-induced Abeta production and Tau phosphorylation via regulating Akt\/GSK-3beta signaling pathway in PC12 cells","volume":"96","author":"Huang","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2025.107849_bib291","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.biopha.2017.05.022","article-title":"Hypericum perforatum extract attenuates behavioral, biochemical, and neurochemical abnormalities in Aluminum chloride-induced Alzheimer's disease rats","volume":"91","author":"Cao","year":"2017","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib292","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.mp.4001866","article-title":"Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits","volume":"11","author":"Dinamarca","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.phrs.2025.107849_bib293","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1042\/bj3220859","article-title":"Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction","volume":"322","author":"Tomiyama","year":"1997","journal-title":"Biochem J."},{"issue":"12","key":"10.1016\/j.phrs.2025.107849_bib294","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1074\/jbc.271.12.6839","article-title":"Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin - Its possible function as a hydroxyl radical scavenger","volume":"271","author":"Tomiyama","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/bbrc.1994.2428","article-title":"Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro","volume":"204","author":"Tomiyama","year":"1994","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib296","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-120319","article-title":"Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease","volume":"31","author":"Qosa","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib297","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bpa.12069","article-title":"St. John's Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein","volume":"24","author":"Brenn","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2025.107849_bib298","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2017.07.038","article-title":"Pregnane X receptor deletion modifies recognition memory and electroencephalographic activity","volume":"370","author":"Boussadia","year":"2018","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib299","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.5650\/jos.ess18117","article-title":"Protective effect of hyperforin on beta amyloid protein induced apoptosis in PC12 cells and colchicine induced Alzheimer's disease: an anti-oxidant and anti-inflammatory therapy","volume":"67","author":"Jiang","year":"2018","journal-title":"J. Oleo Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib300","first-page":"251","article-title":"Rifampicin inhibits apoptosis in rotenone-induced differentiated PC12 cells by ameliorating mitochondrial oxidative stress","volume":"5","author":"Chen","year":"2010","journal-title":"Neural Regen. Res."},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib301","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.phrs.2025.107849_bib302","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainres.2006.12.074","article-title":"Rifampicin protects PC12 cells against MPP+-induced apoptosis and inhibits the expression of an alpha-Synuclein multimer","volume":"1139","author":"Xu","year":"2007","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.107849_bib303","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11064-018-2494-y","article-title":"Rifampicin prevents SH-SY5Y cells from rotenone-induced apoptosis via the PI3K\/Akt\/GSK-3beta\/CREB signaling pathway","volume":"43","author":"Wu","year":"2018","journal-title":"Neurochem. Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib304","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2017.01.100","article-title":"Rifampicin pre-treatment inhibits the toxicity of rotenone-induced PC12 cells by enhancing sumoylation modification of alpha-synuclein","volume":"485","author":"Lin","year":"2017","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2025.107849_bib305","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104690","article-title":"Rifampicin attenuates rotenone-treated microglia inflammation via improving lysosomal function","volume":"63","author":"Liang","year":"2020","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.phrs.2025.107849_bib306","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuro.2017.09.015","article-title":"Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy","volume":"63","author":"Liang","year":"2017","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib307","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.01.116","article-title":"Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain","volume":"1082","author":"Oida","year":"2006","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2025.107849_bib308","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2006.06.018","article-title":"Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice","volume":"249","author":"Mohanasundari","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2025.107849_bib309","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/1871527311312050013","article-title":"Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of Parkinson's disease","volume":"12","author":"del Rio","year":"2013","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.phrs.2025.107849_bib310","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39118-9","article-title":"Pregnane X receptor agonist nomilin extends lifespan and healthspan in preclinical models through detoxification functions","volume":"14","author":"Fan","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2025.107849_bib311","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mad.2013.08.003","article-title":"Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice","volume":"134","author":"Jiang","year":"2013","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.phrs.2025.107849_bib312","article-title":"Targeting farnesoid X receptor as aging intervention therapy","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.phrs.2025.107849_bib313","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112426","article-title":"Constitutive androstane receptor: a peripheral and a neurovascular stress or environmental sensor","volume":"9","author":"Oliviero","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2025.107849_bib314","article-title":"Activation of nuclear receptor CAR: a pathway to delay aging through enhanced capacity for xenobiotic resistance","author":"Yu","year":"2025","journal-title":"Adv. Sci."},{"issue":"18","key":"10.1016\/j.phrs.2025.107849_bib315","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","article-title":"Hepatic soluble epoxide hydrolase activity regulates cerebral Abeta metabolism and the pathogenesis of Alzheimer's disease in mice","volume":"111","author":"Wu","year":"2023","journal-title":"Neuron"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:42:59Z","timestamp":1762353779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":315,"alternative-id":["S1043661825002749"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107849","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detoxification and age-related neurodegenerative diseases: Correlation and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107849"}}